Tuesday, March 21, 2023 | Back issues
Courthouse News Service Courthouse News Service

Biotech IPO

SAN MATEO, Calif. - Pacific Biosciences overstated its prospects to raise $230 million through its initial public offering, at $16 a share, and the stock price sank to $4.25 after this and the company's "cash burn" were revealed, shareholders say in a class action in Superior Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.